— Know what they know.
Not Investment Advice

FEMY NASDAQ

Femasys Inc.
1W: -16.1% 1M: -32.9% 3M: -49.0% YTD: -83.7% 1Y: -72.3% 3Y: -90.6% 5Y: -98.6%
$2.05
-0.05 (-2.38%)
 
Weekly Expected Move ±9.6%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 34 · $6.2M mcap · 2M float · 21.65% daily turnover · Short 24% of daily vol

Supply Chain Overview

2 relationships
1
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2023-11-16
Earliest Filing
2025-07-03
Latest Filing
investor: 1

Counterparties (Filed by FEMY)

1 relationships

Companies named in FEMY's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Alumni Capital LP — investor Purchaser of up to $10 million in shares under an Any Market Purchase Agreement. 2025-07-03 View

Mentioned As Counterparty

1 mentions

Other companies that named FEMY in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
PMCB PharmaCyte Biotech, Inc. investor PharmaCyte Biotech, Inc. purchased senior unsecured convertible notes, Series A and Series B warrants from Femasys Inc. 2023-11-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-14 Earnings Release; Exhibits View
2026-08-11 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-06-24 Other Events; Exhibits View
2026-06-24 Shareholder Vote View
2026-06-05 Bylaws Amendment; Exhibits View
2026-06-04 Regulation FD View
2026-05-13 Regulation FD; Exhibits View
2026-05-08 Earnings Release; Exhibits View
2026-04-29 Shareholder Vote View
2026-04-01 Officer/Director Change; Other Events; Exhibits View
2026-03-31 Earnings Release; Exhibits View
2026-01-15 Notice of Delisting or Transfer View
2025-12-23 Other Events; Financial Statements and Exhibits View
2025-12-18 Other Events; Financial Statements and Exhibits View
2025-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-10 Other Events; Financial Statements and Exhibits View
2025-11-07 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2025-11-03 Other Events; Financial Statements and Exhibits View
2025-10-21 Notice of Delisting or Transfer; Financial Statements and Exhibits View
2025-10-17 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms